Pharmacogenomics
Use of genetic variation to predict drug response, dosing, efficacy, or adverse reactions.
Core metadata
- ID: pharmacogenomics
- Era: Modern
- First known date: 1997 (decade)
- Region: Global genomics and clinical pharmacology
- Review status: source_checked
- Maturity: established
Prerequisites
- Bioinformatics (bioinformatics)
- DNA Sequencing (dna_sequencing)
- Pharmacokinetics and Pharmacodynamics (pharmacokinetics_pharmacodynamics)
Dependents
- None.
Fields
Field lanes
- Pharmaceuticals & Drug Development: Pharmacovigilance & Real-World Evidence
Node sources
- Table of Pharmacogenomic Biomarkers in Drug Labeling (U.S. Food and Drug Administration, 2026, official_agency) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 68%
- Prerequisite sources: 3
- expert_inference: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| DNA Sequencing (dna_sequencing) | enabling | 68% | expert_inference | DNA Sequencing provides a capability that enables this technology without being the only possible path. |
|
| Pharmacokinetics and Pharmacodynamics (pharmacokinetics_pharmacodynamics) | enabling | 68% | expert_inference | Pharmacokinetics and Pharmacodynamics provides a capability that enables this technology without being the only possible path. |
|
| Bioinformatics (bioinformatics) | enabling | 68% | expert_inference | Bioinformatics provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.